Fundz

Who to call at CTMC and Syenex, and when

Fundz watches for the moments CTMC and Syenex starts buying, and tells you who to reach.

  • An alert the day CTMC and Syenex raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CTMC and Syenex, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

CTMC and Syenex Partner to Improve Cell Therapy Scalability

Jan 08, 2025

Contract Type

partnership

HoustonManufacturingBiotechnology

Description

CTMC, a joint venture between MD Anderson Cancer Center and Resilience, has entered a partnership with Syenex to advance the scalability and efficiency of engineered T cell therapies. Through this collaboration, CTMC will gain access to Syenex’s bioengineering systems, which provide a significant improvement in gene delivery efficiency and engineering timelines. The partnership aims to leverage the most advanced tools and technologies to streamline manufacturing and clinical translation.

Company Information

Company

CTMC and Syenex

Location

Houston, Texas, United States

About

CTMC is a joint venture between MD Anderson Cancer Center and Resilience, while Syenex is a company that develops bioengineering systems for cell therapy manufacturing.

Predictive Intelligence
Strategic

ML-powered predictions for CTMC and Syenex's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

CTMC and Syenex signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.